Shenghui Mei

1.0k total citations
70 papers, 763 citations indexed

About

Shenghui Mei is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Psychiatry and Mental health. According to data from OpenAlex, Shenghui Mei has authored 70 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pediatrics, Perinatology and Child Health, 18 papers in Public Health, Environmental and Occupational Health and 17 papers in Psychiatry and Mental health. Recurrent topics in Shenghui Mei's work include Pharmacological Effects and Toxicity Studies (20 papers), Acute Lymphoblastic Leukemia research (17 papers) and Epilepsy research and treatment (17 papers). Shenghui Mei is often cited by papers focused on Pharmacological Effects and Toxicity Studies (20 papers), Acute Lymphoblastic Leukemia research (17 papers) and Epilepsy research and treatment (17 papers). Shenghui Mei collaborates with scholars based in China, United States and Poland. Shenghui Mei's co-authors include Zhigang Zhao, Xingang Li, Yi Liu, Kefu Yu, Weixing Feng, Lijia Guo, Jiaqing Wang, Zhigang Zhao, Jimin Xiong and Songlin Wang and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Journal of Dental Research.

In The Last Decade

Shenghui Mei

63 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenghui Mei China 15 164 126 122 111 107 70 763
Reena Sharma India 21 103 0.6× 251 2.0× 52 0.4× 39 0.4× 47 0.4× 146 1.5k
Pratima Kumari India 12 70 0.4× 190 1.5× 23 0.2× 70 0.6× 37 0.3× 36 694
Marie Baeck Belgium 22 84 0.5× 60 0.5× 328 2.7× 19 0.2× 334 3.1× 103 1.7k
Xiaoming Sun China 21 67 0.4× 596 4.7× 52 0.4× 28 0.3× 49 0.5× 56 1.8k
Marcin Surmiak Poland 21 99 0.6× 506 4.0× 92 0.8× 14 0.1× 45 0.4× 77 1.2k
Laurie S. Conklin United States 18 70 0.4× 538 4.3× 53 0.4× 16 0.1× 42 0.4× 44 1.5k
Hye‐Rim Shin South Korea 17 26 0.2× 296 2.3× 51 0.4× 33 0.3× 36 0.3× 54 848
Tarek Ibrahim United States 22 494 3.0× 155 1.2× 39 0.3× 35 0.3× 155 1.4× 77 1.3k
Yang Tan China 21 71 0.4× 362 2.9× 76 0.6× 12 0.1× 51 0.5× 62 1.3k
Miguel González‐Barcia Spain 20 42 0.3× 188 1.5× 45 0.4× 15 0.1× 191 1.8× 67 1.0k

Countries citing papers authored by Shenghui Mei

Since Specialization
Citations

This map shows the geographic impact of Shenghui Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghui Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghui Mei more than expected).

Fields of papers citing papers by Shenghui Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenghui Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghui Mei. The network helps show where Shenghui Mei may publish in the future.

Co-authorship network of co-authors of Shenghui Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Shenghui Mei. A scholar is included among the top collaborators of Shenghui Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenghui Mei. Shenghui Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wenshu, Ying Li, Lin Fu, et al.. (2025). Risk factors associated with high-dose methotrexate induced toxicities in primary central nervous system lymphoma. Frontiers in Pharmacology. 16. 1561818–1561818. 1 indexed citations
2.
Zhang, Dongjie, Qian Lü, Lili Guan, et al.. (2025). Population pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma. Frontiers in Pharmacology. 16. 1578033–1578033. 1 indexed citations
3.
Zhang, Dongjie, et al.. (2024). Population Pharmacokinetics of Lamotrigine and Its N2-Glucuronide Metabolite in Chinese Patients With Epilepsy. Therapeutic Drug Monitoring. 46(5). 649–657.
4.
Xiao, Ning, Lulu Wang, Jia-Sheng Wang, et al.. (2024). High-Coverage UHPLC-MS/MS Analysis of 67 Mycotoxins in Plasma for Male Infertility Exposure Studies. Toxics. 12(6). 395–395. 6 indexed citations
6.
Jiang, Ruiqi, et al.. (2023). Simultaneous determination of 24 antiepileptic drugs and their active metabolites in human plasma by UHPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 232. 115437–115437. 5 indexed citations
8.
10.
Wu, Han, Qiang Zhang, Zhigang Zhao, et al.. (2023). Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy. European Journal of Pediatrics. 182(10). 4509–4521. 5 indexed citations
11.
Zhang, Qiang, Han Wu, Yun Wu, et al.. (2023). Population pharmacokinetics of topiramate in Chinese children with epilepsy. European Journal of Clinical Pharmacology. 79(10). 1401–1415. 3 indexed citations
12.
Zhang, Yiming, Xinwei Chen, Libo Zhao, et al.. (2022). A Systematic Review of Population Pharmacokinetic Models of Methotrexate. European Journal of Drug Metabolism and Pharmacokinetics. 47(2). 143–164. 14 indexed citations
13.
Liu, Yang, Yang Liu, Dongjie Zhang, et al.. (2019). Simultaneous determination of plasma nicotine and cotinine by UHPLC–MS/MS in C57BL/6 mice and its application in a pharmacokinetic study. Biomedical Chromatography. 33(10). 7 indexed citations
14.
Mei, Shenghui, Weixing Feng, Xingang Li, et al.. (2018). Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model. European Journal of Clinical Pharmacology. 74(8). 1029–1036. 24 indexed citations
15.
Mei, Shenghui, Xindi Li, Xiaoqing Gong, et al.. (2017). Comparison of 6‐mercaptopurine with 6‐thioguanine for the analysis of thiopurine S‐methyltransferase activity in human erythrocyte by LC–MS/MS. Biomedical Chromatography. 31(9). 5 indexed citations
16.
Du, Jie, et al.. (2017). Platelet‐rich fibrin/aspirin complex promotes alveolar bone regeneration in periodontal defect in rats. Journal of Periodontal Research. 53(1). 47–56. 38 indexed citations
17.
Mei, Shenghui, Jiaqing Wang, Ruiling Chen, et al.. (2017). A UPLC–MS/MS method for analysis of vancomycin in human cerebrospinal fluid and comparison with the chemiluminescence immunoassay. Biomedical Chromatography. 31(8). 7 indexed citations
18.
Li, Xingang, Shusen Sun, Shenghui Mei, et al.. (2015). Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients. Journal of Pharmaceutical Sciences. 104(11). 3960–3967. 35 indexed citations
19.
Cao, Yu, Jimin Xiong, Shenghui Mei, et al.. (2015). Aspirin promotes bone marrow mesenchymal stem cell-based calvarial bone regeneration in mini swine. Stem Cell Research & Therapy. 6(1). 210–210. 71 indexed citations
20.
Mei, Shenghui, Jiawang Liu, Ming Zhao, et al.. (2011). From Cerius2 based stereoview to mouse and enzyme: the model systems for discovery of novel urokinase inhibitors. Molecular BioSystems. 7(9). 2664–2669. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026